Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash Flows from Operating Activities:
Net Loss	$ (1,322,199)	$ (2,007,099)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	258,048	286,549
Stock-based compensation expense	81,233	258,894
Accretion for debt discounts and issuance costs	$ 384,026	131,796
Warrants issued in exchange for services		$ 20,752
Fair value of embedded conversion feature	$ 1,091
Changes in operating assets and liabilities:
Accounts receivable	(2,145)	$ 1,089
Prepaid expenses and other current assets	(8,592)	7,436
Accounts payable	131,755	$ 243,382
Other assets	16,995
Accrued interest and other liabilities	272,177	$ (2,479)
Deferred revenue	$ (52,363)	(34,000)
Deferred rent		3,773
Net Cash Used in Operating Activities	$ (239,974)	$ (1,089,907)
Cash Flows From Investing Activities:
Payment for patent and trademark applications	(1,400)
Payment of platform development costs	(71,583)	$ (328,719)
Net Cash Used in Investing Activities	(72,983)	$ (328,719)
Cash Flows from Financing Activities:
Proceeds from issuance of debentures	319,000
Repayments on notes payable related parties	$ (4,162)	$ (252)
Proceeds from issuance of convertible note payable		100,000
Sale of common stock, net of issuance costs		556,200
Net Cash Provided by Financing Activities	$ 314,838	655,948
Net Increase (Decrease) in Cash and Cash Equivalents	1,881	(762,678)
Cash, Beginning of Period	14,119	812,064
Cash, End of Period	$ 16,000	49,386
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for interest		$ 9,603
Non-cash Investing and Financing Transactions:
Accrued interest reclassed to debenture principal	$ 41,750
Conversion of debt to common stock shares	45,953
Discount related to issuance of debt with warrants and allocated fair value to beneficial conversion feature	$ 274,122